described. We sought to review both the fetal cardiac and extracardiac findings associated with a 11 cohort of cases ascertained prenatally, confirmed or suspected to have 22q11.2DS, born and cared 12 for in one center. A retrospective chart review was performed on a total of 42 cases with con-13 firmed 22q11.2DS to obtain prenatal findings, perinatal outcomes and diagnostic confirmation. 14 The diagnosis was confirmed prenatally in 67% (28/42) and postnatally in 33% (14/42). The major-15 ity (81%) were associated with the standard LCR22A-LCR22D deletion. 95% (40/42) of fetuses 16 were prenatally diagnosed with congenital heart disease. Extracardiac findings were noted in 90%
17
(38/42) of cases. Additional findings involved the central nervous system (38%), gastrointestinal 18 (14%), genitourinary (16.6%), pulmonary (7%), skeletal (19%), facial dysmorphism (21%), small/ 19 hypoplastic thymus (26%), and polyhydramnios (30%). One patient was diagnosed prenatally with 20 a bilateral cleft lip and cleft palate. No fetus was diagnosed with intrauterine growth restriction. 21 The average gestational age at delivery was 38 weeks and average birth weight was 3,105 grams. 22 Sixty-two percentage were delivered vaginally and there were no fetal demises. A diagnosis of 23 22q11.2 deletion syndrome should be considered in all cases of prenatally diagnosed congenital 24 heart disease, particularly when it is not isolated. Microarray is warranted in all cases of structural 25 abnormalities diagnosed prenatally. Prenatal diagnosis of 22q11.2 syndrome can be used to coun-26 sel expectant parents regarding pregnancy outcome and guide neonatal management. 34 mon and well-described microdeletion syndromes, with a broad 35 reported prevalence between 1 in 2,000 and 6,000 live births (Bassett 36 et al., 2011) . Currently, the most well documented prenatal phenotype 37 associated with 22q11.2DS is congenital heart disease, specifically 38 right-sided conotruncal anomalies. Additional associations include cleft 39 lip/palate, as well as fetal growth restriction (Noel et al., 2014 (Table  T2  2 Table  T3 3. 136 No fetuses were diagnosed with intrauterine growth restriction (IUGR). Noel et al., 2003; Volpe et al., 2003) . (Chaoui et al., 2011 (Chaoui et al., , 2002 . The fetal thymus is well developed by this (Davidson, Khandelwal, & 216 Punnett, 1997; Nickel & Magenis, 1996; Nickel et al., 1994) . identified dilated cavum septum pellucidum, above 95% for gestational 227 age, in over 67% of their cohort of 37 fetal cases (Chaoui et al., 2016) . 228 Skeletal anomalies have been reported infrequently as a rare asso-229 ciation with 22q11.2DS. We report skeletal findings in 19% of our 230 cohort that include anomalous vertebrae (4/8) and bilateral talipes (2/ 231 8). In a study of 108 patients with 22q11.2DS, 36% had a skeletal 232 anomaly including these two findings (Ming et al., 1997) . Bilateral tali-233 pes has also been noted in many multicenter prenatal case series, both 234 with and without mention of congenital heart disease, proving that it is 235 an important and often overlooked association with the condition.
236
In the present study, pyelectasis was the most common genitouri-237 nary finding. We additionally report an individual who did not have 238 congenital heart disease, but had unilateral multicystic dysplastic kidney n/a n/a n/a 7 (25%) 17 (61%) n/a Boudjemline et al.
AQ18 54 100% FISH 54 (100%) n/a n/a n/a n/a 16 (29.8%) n/a n/a n/a n/a 13 (24%) n/a CNS 5 central nervous system; GI 5 gastrointestinal; GU 5 genitourinary; IUGR 5 intrauterine growth restriction. Kujat, Zelante, & Froster, 2006) . Rarely has TEF been detected prena-257 tally (Boudjemline et al., 2001; Sundaram et al., 2007 Better defining the extracardiac prenatal associations will aid in under-343 standing the true prevalence of disease as well as raise awareness 344 among those diagnosing and treating these patients.
345
Although this is a large cohort of 22q11.2DS fetuses evaluated 346 and delivered in one center, the study has many weaknesses. The man-347 ner in which the cohort was obtained required that the diagnosis was 
